<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.2d1 20170631//EN" "JATS-journalpublishing1.dtd">
<article xlink="http://www.w3.org/1999/xlink" dtd-version="1.0" article-type="healthcare" lang="en"><front><journal-meta><journal-id journal-id-type="publisher">IJCRR</journal-id><journal-id journal-id-type="nlm-ta">I Journ Cur Res Re</journal-id><journal-title-group><journal-title>International Journal of Current Research and Review</journal-title><abbrev-journal-title abbrev-type="pubmed">I Journ Cur Res Re</abbrev-journal-title></journal-title-group><issn pub-type="ppub">2231-2196</issn><issn pub-type="opub">0975-5241</issn><publisher><publisher-name>Radiance Research Academy</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">4191</article-id><article-id pub-id-type="doi"/><article-id pub-id-type="doi-url"> http://dx.doi.org/10.31782/IJCRR.2021.132014</article-id><article-categories><subj-group subj-group-type="heading"><subject>Healthcare</subject></subj-group></article-categories><title-group><article-title>Role of Endothelial Dysfunction in Cardiovascular Disease:__ampersandsignnbsp;Potential Therapeutic Target&#13;
</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Oleksii</surname><given-names>Korzh</given-names></name></contrib></contrib-group><pub-date pub-type="ppub"><day>24</day><month>10</month><year>2021</year></pub-date><volume>0)</volume><issue/><fpage>170</fpage><lpage>173</lpage><permissions><copyright-statement>This article is copyright of Popeye Publishing, 2009</copyright-statement><copyright-year>2009</copyright-year><license license-type="open-access" href="http://creativecommons.org/licenses/by/4.0/"><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution (CC BY 4.0) Licence. You may share and adapt the material, but must give appropriate credit to the source, provide a link to the licence, and indicate if changes were made.</license-p></license></permissions><abstract><p>Introduction: The vascular endothelium is a layer of endothelial cells lining the lumen of blood vessels, lymphatic vessels, the heart and other organs. Normal endothelium protects cardiovascular diseases, while vascular endothelial pathology is the main cause of many cardiovascular diseases. Aim: Here we summarize current knowledge about endothelial function from bench to bedside. Methods: We review the studies demonstrating the significance of vascular endothelium and evaluating the potential role of drugs targeting endothelial function in the management of cardiovascular diseases. Results: Endothelial dysfunction is a discovered phenomenon that makes a significant contribution to the pathophysiology of numerous cardiovascular conditions associated with vasoconstriction, thrombosis and inflammatory conditions. In clinical settings, the assessment of endothelial functions is attracting increasing attention due to its growing importance for cardiovascular diseases. Since cardiovascular endothelial dysfunction is also detected in patients with heart failure, it is expected to play an important role as a predictive predictor of cardiovascular events. Moreover, vascular endothelial function may be the goal of a comprehensive treatment of diseases for the prevention of cardiovascular diseases. Conclusion: Recent publications have highlighted emerging modulators of endothelial functions, and potential therapeutic and diagnostic goals with major clinical consequences.&#13;
</p></abstract><kwd-group><kwd>Endothelium</kwd><kwd> Endothelial dysfunction</kwd><kwd> Cardiovascuar disease</kwd><kwd> Hypertension</kwd><kwd> Treatment</kwd><kwd> New agents</kwd><kwd> A terap glucagonlike takimoto peptide jmc-1 receptor agonist</kwd></kwd-group></article-meta></front></article>
